Feedback PLC (LON:FDBK) said Bleepa, its flagship medical imaging communications, was granted the UK Conformity Assessed (UKCA) mark.
The UKCA is a post-Brexit replacement for the CE mark and is designed to demonstrate conformity with relevant UK legislation across a range of products from medical devices to factory machinery.
Feedback said the UKCA mark added to its portfolio of regulatory approvals for Bleepa.
“In addition to the CE mark affixed last year, Bleepa has now enhanced its regulatory technical file to include the UK’s Medical Device Manufacturing mark,” said the company’s chief executive, Tom Oakley.
“The new UK product marking is used for goods being placed on the market in Great Britain post-BREXIT and further validates as well as provides confidence in the quality and expertise of Bleepa’s technology.”